Precision injectable therapeutics.
A portfolio of multidose prefilled pens and lyophilised vial presentations, built on one device platform and one packaging standard.
Catalogue specifications
- Product range
- 11 presentations
- Storage specification
- 2 to 8 °C
- Pen format
- 3 ml reservoir
Portfolio
Featured presentations
GLP 1 receptor agonist
Semaglutide 5 mg
5 mg / 3 ml prefilled pen for subcutaneous use.
View details →
Dual GIP/GLP 1 receptor agonist
Tirzepatide 20 mg
20 mg / 3 ml prefilled pen for subcutaneous use.
View details →
Dual GIP/GLP 1 receptor agonist
Tirzepatide 40 mg
40 mg / 3 ml prefilled pen for subcutaneous use.
View details →
Triple receptor agonist
Retatrutide 20 mg
20 mg / 3 ml prefilled pen for subcutaneous use.
View details →
Triple receptor agonist
Retatrutide 40 mg
40 mg / 3 ml prefilled pen for subcutaneous use.
View details →
Lyophilised peptide
Retaovotride 20 mg
20 mg lyophilised vial supplied with 0.9% saline ampoule.
View details →One standard across the range
Strength, concentration and route sit on the principal panel of every carton. Pens share a dose window, dial feedback and cap colour system, so identification is immediate and consistent between products.
About OVO PharmaceuticalsPrefilled pens
3 ml multidose reservoir with graduated titration.
Lyophilised vials
Supplied with a 0.9% saline ampoule for reconstitution.
Serialised cartons
Batch, expiry and unique identifier in fixed positions.
Single patient use
Marked clearly on the principal display panel.
Questions about a specific presentation?
Our medical information team answers specification, packaging and handling questions from healthcare professionals.
Contact us